Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
about
Ceruloplasmin as a prognostic marker in patients with bile duct cancer.Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.Pathogenesis, diagnosis, and management of cholangiocarcinomaIL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanismHigh level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell linesFGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancerThe challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.Retinoic acid inhibits the cytoproliferative response to weak 50‑Hz magnetic fields in neuroblastoma cells.Epidermal growth factor upregulates Skp2/Cks1 and p27(kip1) in human extrahepatic cholangiocarcinoma cellsThe role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies.Effect of brefelamide on HGF-induced survival of 1321N1 human astrocytoma cells.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6KThe BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics.Proteinase-activated receptor 2 (PAR(2)) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level.
P2860
Q33709983-EA7C4BA7-DD62-4E43-A670-3DE5A7570E9EQ34079007-F4B5B958-939E-4C84-9F47-96AE0E9E2924Q34656747-DF5F686A-F29B-4CFA-879A-EC9561DF00A5Q35528356-0638AD6E-C3AD-479E-A9F4-AA643A8B7715Q35681554-BBCA4143-DD54-4E76-A4AF-EA389DF91B91Q35922535-151147F4-5786-47B3-A3C0-74571B6F4AF9Q36036046-79B966DB-FD32-43B4-869E-534F770BC54CQ36262850-953B83AF-6789-4924-81D0-41E6D239FBA4Q36547939-E2BE308B-10CA-4C1B-AB73-1E97F0D74CA2Q36683019-686AE472-3E21-42B9-B55E-333B7650B7C2Q36684628-B5E676AE-69B9-430A-8992-BA4FB8BE9FE7Q37578594-D6E674CA-6E62-4772-85D4-34F760AA478CQ37964960-B7600279-ED1D-4683-959C-B226CC20BBAEQ38397298-76299257-C5D6-436B-8E9B-B3EA90212F9CQ38774306-A175DED3-29DA-4465-848C-A3AD36E11830Q38812588-0FA24497-B8E1-4B24-BA16-69730DD9224FQ39129195-461F2670-3013-4A22-9C4E-1DB4D357E1C1Q39211399-A21E8A2A-7F22-47D6-802C-F9A57B7FC8BEQ39664471-4ED06A00-C2B3-4929-BB50-D3BA71215735Q39703338-71DD2B21-481A-4944-898C-2E9AD845936EQ41670789-AAD95A18-EFD9-4265-9A27-FBA2ADC07519Q45101582-0FAE918A-ED9D-4067-BB3A-24009674E451Q47603972-37EC5FD3-279B-415A-A3A4-4BFB34B58212Q48214526-5C5BD78A-470E-4409-80BF-8AA7D925CD00Q54490877-6452FAE7-7755-481B-A84F-7EFA01DC6B0F
P2860
Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@ast
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@en
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@nl
type
label
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@ast
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@en
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@nl
prefLabel
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@ast
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@en
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@nl
P2860
P356
P1476
Involvement of PI3K and ERK1/2 ...... langiocarcinoma cell invasion.
@en
P2093
Apaporn Menakongka
Tuangporn Suthiphongchai
P2860
P304
P356
10.3748/WJG.V16.I6.713
P407
P577
2010-02-01T00:00:00Z